Now Reading
IIT Kharagpur Launches COVIRAP For Rapid COVID Diagnostics

IIT Kharagpur Launches COVIRAP For Rapid COVID Diagnostics

Indian Institute of Technology, Kharagpur announced the launch of its flagship healthcare product called COVIRAP. COVIRAP is a diagnostic technology that can be used for detecting infectious diseases including COVID-19 and beyond. 

The product has been developed by lead researchers Professor Suman Chakraborty, Dr Arindam Mondal and their research group. According to its official blog post, “The research team has now developed a more advanced version of COVIRAP using a stepwise isothermal nucleic acid testing technology for the rapid diagnostics of pathogenic infections including SARS-CoV-2 in individuals.”

Register for FREE Workshop on Data Engineering>>

Director Prof. V K Tewari at IIT, Kharagpur stated, “The above move has taken place at a critical juncture when the recent spurt in COVID-19 infection, commonly known as the second wave, has been threatening to spread more rapidly than ever before.” 

“Moreover, the commercialization of COVIRAP will initiate complete indigenization and availability of a large range of affordable healthcare products in the Indian market as well as deep trenches of a large global market that is literally starving for the need of such technology. COVIRAP promises its reach to the grass-root level in catering to the needs of the last person of the society,” Tiwari added.

See Also
IIT Kharagpur Sets Up AI & ML Innovation Hub To Transform The Industrial Sector With Scalable Application

The COVID-19 diagnostic test can be conducted directly from human swab samples in the portable device developed by the team, without requiring any separate facility for RNA extraction. The results can be made available within 45 minutes of obtaining the patient sample. The kit has also been supplemented with a free smartphone app to facilitate unambiguous results interpretation and automated dissemination to the patients. 
Bramerton Holdings has signed a record deal for securing global rights for commercially disseminating the COVIRAP technology developed at IIT Kharagpur in various geographical locations outside the territory of the Indian subcontinent.  Rapid Diagnostic has also initiated adapting the COVIRAP technology platform for COVID-19 and tuberculosis, in collaboration with IIT Kharagpur.

Subscribe to our Newsletter

Get the latest updates and relevant offers by sharing your email.
Join our Telegram Group. Be part of an engaging community

Copyright Analytics India Magazine Pvt Ltd

Scroll To Top